News
Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...
AstraZeneca is capping patients’ out-of-pocket expenses for inhaled respiratory medicines at $35 per month, effective June 1.. The move announced by the Big Pharma company Monday comes amid ...
AstraZeneca Latest News . February 11, 2025, 2:32 PM EST Commercial Real Estate. 20 Greater Philadelphia projects to watch in 2025. 20 Greater Philadelphia projects to watch in 2025. January 16, ...
The NFL failed to ban the "Tush Push" at the league meetings, meaning the controversial play made famous by the Philadelphia Eagles is here to stay.
Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined. Philadelphia news 24/7: Watch NBC10 free wherever you are ...
This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...
Hosted on MSN3mon
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe - MSNBritish pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China. Under the deal, AstraZeneca will enter ...
WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of hormone receptor (HR)-positive, HER2-negative advanced ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and tolerable in an early-stage trial, with side effects ...
Unites Pharma Marketing, PR & Communications, New Product Planning & Commercialization, and Medical Affairs Communities; ...
AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.
AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines.. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results